Highly Sensitive Lens culinaris Agglutinin-Reactive α-Fetoprotein: A New Tool for the Management of Hepatocellular Carcinoma
Authors:
- Takashi KumadaTKTakashi Kumada
- Toshifumi TadaTTToshifumi Tada
- 1 December 2011
- journal article
- review article
- Published by S. Karger AG in Oncology
- Vol. 81 (Suppl. 1) , 61-65
Abstract
Objectives: The highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein (hs-AFP-L3), measured using a newly developed method involving microfluidics-based separation technology, was evaluated as a new tool for the management of hepatocellular carcinoma (HCC) in clinical practice. Methods: The sensitivity and specificity of hs-AFP-L3 for the diagnosis of HCC and its ability to predict the outcome of patients with HCC were analyzed based on reported studies. Results: Compared to AFP-L3 measured using conventional methods, the sensitivity of hs-AFP-L3 was markedly higher and the specificity was comparable. In all studies, multivariate analysis found that elevation of hs-AFP-L3 was an independent factor that affected patient survival. Conclusions: The use of hs-AFP-L3 improves the true positive rate of patients with HCC at diagnosis, maintaining the high specificity of AFP-L3 and its indicative value for poor prognosis. The utility of this tumor marker for prediction of the development of HCC in high-risk patients under surveillance needs to be investigated.Keywords
This publication has 22 references indexed in Scilit:
- Prognostic importance of fucosylated alpha‐fetoprotein in hepatocellular carcinoma patients with low alpha‐fetoproteinJournal of Gastroenterology and Hepatology, 2011
- Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virusJournal of Gastroenterology, 2010
- Clinical Advantage of Highly Sensitive On-Chip Immunoassay for Fucosylated Fraction of Alpha-Fetoprotein in Patients with Hepatocellular CarcinomaDigestive Diseases and Sciences, 2010
- Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinomaHepatology Research, 2007
- Fucosylated fraction of alpha‐fetoprotein, L3, as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha‐fetoproteinHepatology Research, 2007
- Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C TrialJournal of Hepatology, 2005
- Relationship between Lens culinaris agglutinin‐reactive α‐fetoprotein and pathologic features of hepatocellular carcinomaLiver International, 2005
- Serum alpha‐fetoprotein and lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein in patients with hepatocellular carcinomaLiver International, 1993
- Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinomaJournal of Hepatology, 1987
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaNew England Journal of Medicine, 1984